Meet Element Biosciences at the Molecular and Precision Med Tri-Con

Meet Element Biosciences at the Molecular and Precision Med Tri-Con

Booth #322

DON'T MISS Element CEO & Co-Founder Molly He at #TRICON! She will be participating in the keynote panel discussion: 30 Years of Genomics Innovation and the Future of Precision Medicine. The panel will discuss scientific highlights of an extraordinary journey for practitioners of precision medicine and anticipate where the field is headed. While you're there, stop by BOOTH #322 to meet our team and learn about the AVITI™ system, our DNA sequencing platform that offers industry-leading data quality at the lowest run costs.

Panel discussion details featuring Molly He:
Monday March 6, 4:15 pm PANEL DISCUSSION: 30 Years of Genomics Innovation and the Future of Precision Medicine

Moderator: Kevin Davies, PhD, Executive Editor, The CRISPR Journal; Author, Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing

Over the past three decades, genomic medicine has been transformed from a distant dream to a clinical reality. With patients suffering genetic diseases and cancer now cured thanks to advances in genomics, cell therapy, genome editing, and computing, the future is bright – but by no means assured. In this TRI-CON keynote panel, we discuss the scientific highlights of an extraordinary journey for practitioners of precision medicine and anticipate where the field is headed.

Other panelists: Euan Ashley, MD, PhD, Professor, Genomics & Precision Health, Stanford School of MedicineJ. Craig Venter, PhD, Founder, Chairman, and CEO, J. Craig Venter InstituteMolly He, PhD, CEO & Co Founder, Element BiosciencesAlex Aravanis, MD, PhD, CTO, Senior Vice President, Head of Research and Product Development, Illumina